The Policy and Ethics Committee (PEC)
formerly known as Public and Professional Policy Committee (PPPC)
Members of the PEC 2024
3-year term ends | Term | |
Olga Antonova (Observer) (Sofia, Bulgaria) | since 2022 | n/a |
Christophe Cordier (Lausanne, Switzerland) | 2026 | 3rd |
Angus Clarke (Cardiff, United Kingdom) | 2025 | 3rd |
Guido de Wert (Maastricht, The Netherlands) | 2024 | 3rd |
Roseline Favresse (Nice, France) | since 2024 | 1st |
Francesca Forzano (London, United Kingdom) - Chair | 2026 | 6th |
Sabine Hentze (Heidelberg, DE) | 2024 | 2nd |
Heidi Howard (Uppsala, Sweden) | 2024 | 4th |
Yalda Jamshidi (Observer) (London, United Kingdom) | since 2022 | n/a |
Milan Macek (Prague, Czech Republic) | 2026 | 2nd |
Bela Melegh (Pecs, Hungary) | 2024 | 3rd |
Alvaro Mendes (Porto, Portugal) | 2024 | 3rd |
Yves Moreau (Leuven, Belgium) | 2024 | 1st |
Markus Perola (Helsinki, Finland) | 2025 | 3rd |
Inga Prokopenko (Guildford, Surrey, United Kingdom) | 2026 | 2nd |
Dragica Radojkovic (Belgrade, Serbia) | 2024 | 4th |
Emmanuelle Rial-Sebbag (Toulouse, France) | 2026 | 4th |
Vigdis Stefánsdottir (Reykjavik, Iceland) | 2026 | 3rd |
Fiona Ulph (Manchester, United Kingdom) | 2024 | 1st |
Carla van El (Amsterdam, The Netherlands) - Secretary General | 2025 | 3rd |
What do we do?
The Policy and Ethics Committee (PEC) is an interdisciplinary Committee of the ESHG constituted at its 1997 annual meeting. At the time it became increasingly clear that fast technological developments called for thorough discussions and clear statements regarding their professional and societal ramifications.
It is the mission of PEC to contribute to the responsible translation of advancements in human genetics, and therefore its members aim
- to identify and discuss the ethical, social and policy issues related to human genetics and its application in research, clinical practice and laboratory genetic services.
- to be informed of various research projects, conferences and events, as well as policy initiatives and actions relating to those issues
- to inform and stimulate the discussion around these issues at meetings
- to address these issues and provide guidance through background documents, policy statements, recommendations or other publications
- to participate in the public and professional debate around these issues
- to inform, interact with and provide advice to national and international policy makers
Over the years numerous documents have been produced, often in collaboration with external experts. In some cases, draft documents are distributed to the ESHG membership for consultation. In all cases documents are to be endorsed by the ESHG Board. Recent publications are listed below.
Currently, the PEC is working on statements regarding opportunistic genomic screening and on GDPR. The Committee collaborates with a range of other societies and organisations such as ASHG-Social Issues Committee, ELPAG and ESHRE
The PEC has vacancies regularly for a new member who may serve a three-year term. In addition, external experts can request or can be invited to work on specific topics and become a PEC collaborator. For the composition of the group expertise in a range of subjects and professional backgrounds is taken into account; members should have experience with or proven interest in policy issues regarding genetics and be motivated to work on specific topics, most notably by preparing documents. Ideally members come from different regions in Europe.
The PEC meets twice a year. The ESHG President, Vice-President and President-Elect are ex-officio members. Since 2012, the PEC has a liaison member to the SPC (currently Francesca Forzano).
ESHG members interested in becoming a PEC member are requested to send their CV and a letter of interest stating their expertise and motivation for joining to the Chair, Francesca Forzano Francesca.Forzano(at)gstt.nhs.uk ESHG members having suggestions for new topics to work on, or interested in working on a specific topic as a collaborator are also encouraged to contact PEC via the same email address.
Recommendations
Post mortem genetic testing
European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Fellmann F, van E, C.G, Charron, P, et al. on behalf of European Society of Human Genetics, European Council of Legal Medicine, European Society of Cardiology working group on myocardial and pericardial diseases, European Reference Network for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Association for European Cardiovascular Pathology. Eur J Hum Genet 27, 1763–1773 (2019).
ESHG PPPC Comments on postmortem use of genetic data for research purposes. Fellmann, F., Rial-Sebbag, E., Patch, C. et al. Eur J Hum Genet 28, 144–146 (2020). https://doi.org/10.1038/s41431-019-0525-z
Gene editing
Background document:
Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE. De Wert G, Heindryckx B, Pennings G, Clarke A, Eichenlaub-Ritter U, van El CG, Forzano F, Goddijn M, Howard HC, Radojkovic D, Rial-Sebbag E, Dondorp W, Tarlatzis BC, Cornel MC; European Society of Human Genetics and the European Society of Human Reproduction and Embryology Eur J Hum Genet. 2018 Jan 12. doi: 10.1038/s41431-017-0077-z.
Recommendations:
Human germline gene editing: Recommendations of ESHG and ESHRE.De WertG, Pennings G, Clarke A, Eichenlaub-Ritter U, van El CG, Forzano F, Goddijn M, Heindryckx B, Howard HC, Radojkovic D, Rial-Sebbag E, Tarlatzis BC, Cornel MC; European Society of Human Genetics and the European Society of Human Reproduction and Embryology. Eur J Hum Genet. 2018 Jan 12. doi: 10.1038/s41431-017-0076-0.
Points and questions to consider:
One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans. Howard HC, van El CG, Forzano F, Radojkovic D, Rial-Sebbag E, de WertG, Borry P, Cornel MC; Public and Professional Policy Committee of the European Society of Human Genetics Eur J Hum Genet. 2018 Jan;26(1):1-11. doi: 10.1038/s41431-017-0024-z.
NIPT
Background document including Recommendations:
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening (and Erratum) Dondorp W, De Wert G, Bombard Y, Bianchi DW, Bergmann C, Borry P, Chitty LS, Fellmann F, Forzano F, Hall A, Henneman L, Howard HC, Lucassen A, Ormond K, et al, on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG). Eur J Hum Genet 2015;23:1438-1450.
Summary and Recommendations: Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Summary and recommendations. Dondorp W, De Wert G, Bombard Y, Bianchi DW, Bergmann C, Borry P, Chitty LS, Fellmann F, Forzano F, Hall A, Henneman L, Howard HC, Lucassen A, Ormond K, et al, on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG). Eur J Hum Genet advance online publication 1 April 2015; doi: 10.1038/ejhg.2015.56
Expanded carrier screening
Background document including Recommendations
Responsible implementation of expanded carrier screening. Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, Hall A, Howard HC, Janssens S, Kayserili H, Lakeman P, Lucassen A, Metcalfe SA, Vidmar L, de Wert G, Dondorp WJ, Peterlin B, on behalf of the European Society of Human Genetics. Eur J Hum Genet 2016;24:e1-e12.
Summary and Recommendations:
Responsible implementation of expanded carrier screening: Summary and recommendations of the European Society of Human Genetics. Henneman L,Borry P, Chokoshvili, D Cornel MC, van El CG, Forzano F, Hall A, Howard HC, Janssens S, Kayserili H, Lakeman P, Lucassen A, Metcalfe SA, Vidmar L, de Wert G, Dondorp WJ, Peterlin B, on behalf of the European Society of Human Genetics. Eur J Hum Genet 2016; 24: 781–783.
Whole-genome sequencing
Recommendations:
Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. https://www.ncbi.nlm.nih.gov/pubmed/23676617van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, Howard HC, Cambon-Thomsen A, Knoppers BM, Meijers-Heijboer H, Scheffer H, Tranebjaerg L, Dondorp W, de Wert GM; ESHG Public and Professional Policy Committee.
Eur J Hum Genet. 2013 Jun;21(6):580-4. doi: 10.1038/ejhg.2013.46. No abstract available.
Whole-genome sequencing/Newborn screening
Statement:
Whole-genome sequencing in newbornscreening? A statementon the continuedimportanceof targetedapproachesin newbornscreeningprogrammes.Howard HC, Knoppers BM, Cornel MC, Wright Clayton E, Sénécal K, Borry P; European Society of Human Genetics; P3G International Paediatric Platform; Human Genome Organisation; and the PHG Foundation.
Eur J Hum Genet. 2015 Dec;23(12):1593-600. doi: 10.1038/ejhg.2014.289. Epub 2015 Jan 28.
Common disorders
Background document:
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.Becker F, van El CG, Ibarreta D, Zika E, Hogarth S, Borry P, Cambon-Thomsen A, Cassiman JJ, Evers-Kiebooms G, Hodgson S, Janssens AC, Kaariainen H, Krawczak M, Kristoffersson U, Lubinski J, Patch C, Penchaszadeh VB, Read A, Rogowski W, Sequeiros J, Tranebjaerg L, van Langen IM, Wallace H, Zimmern R, Schmidtke J, Cornel MC
Eur J Hum Genet. 2011 Apr;19 Suppl 1:S6-44. doi: 10.1038/ejhg.2010.249.
Recommendations:
Genetic testing and common disorders in a public health framework.
van El CG, Cornel MC; ESHG Public and Professional Policy Committee.
Eur J Hum Genet. 2011 Apr;19(4):377-81. doi: 10.1038/ejhg.2010.176.
Minors
Recommendations:
Genetic testingin asymptomaticminors: Recommendationsof the EuropeanSocietyof Human Genetics.
Eur J Hum Genet. 2009 Jun;17(6):720-1. doi: 10.1038/ejhg.2009.26. Epub 2009 Mar 11. No abstract available.
Background document:
Genetic testingin asymptomaticminors: background considerations towards ESHG Recommendations.Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K; Public and Professional Policy Committee (PPPC) of the EuropeanSocietyof Human Genetics(ESHG).
Eur J Hum Genet. 2009 Jun;17(6):711-9. doi: 10.1038/ejhg.2009.25. Epub 2009 Mar 11.
Genetic services
Review:
Provisionof genetic servicesin Europe:currentpracticesand issues.Godard B, Kääriäinen H, Kristoffersson U, Tranebjaerg L, Coviello D, Aymé S. Eur J Hum Genet. 2003 Dec;11 Suppl 2:S13-48. Review.
Recommendations:
Provisionof genetic servicesin Europe:currentpracticesand issues.
Eur J Hum Genet. 2003 Dec;11 Suppl 2:S2-4.
Provisionof genetic servicesin Europe: currentpracticesand issues.
Eur J Hum Genet. 2003 Dec;11(12):900-2.
Patents
Patentingand licensingin genetictesting: recommendationsof the EuropeanSocietyof HumanGenetics.Aymé S, Matthijs G, Soini S; ESHG Working Party on Patentingand Licensing.
Eur J Hum Genet. 2008 May;16 Suppl 1:S10-9. doi: 10.1038/ejhg.2008.37.
Reproductive technologies
Current issues in medically assistedreproductionand geneticsin Europe: research, clinical practice, ethics, legal issues and policy: European Society of Human Geneticsand European Society of Human Reproductionand Embryology.Joyce C Harper, Joep Geraedts, Pascal Borry, Martina C Cornel, Wybo Dondorp, Luca Gianaroli, Gary Harton, Tanya Milachich, Helena Kääriäinen, Inge Liebaers, Michael Morris, Jorge Sequeiros, Karen Sermon, Françoise Shenfield, Heather Skirton, Sirpa Soini, Claudia Spits, Anna Veiga, Joris Robert Vermeesch, Stéphane Viville, Guido de Wert, Milan Macek, Jr. Eur J Hum Genet. 2013 Nov; 21(Suppl 2): S1–S21. Published online 2013 Nov 14. doi: 10.1038/ejhg.2013.219
The interfacebetween assistedreproductivetechnologiesand genetics: technical, social, ethicaland legalissues.Soini S, Ibarreta D, Anastasiadou V, Aymé S, Braga S, Cornel M, Coviello DA, Evers-Kiebooms G, Geraedts J, Gianaroli L, Harper J, Kosztolanyi G, Lundin K, Rodrigues-Cerezo E, Sermon K, Sequeiros J, Tranebjaerg L, Kääriäinen H; ESHG; ESHRE. Eur J Hum Genet. 2006 May;14(5):588-645.
The need for interaction between assisted reproduction technology and genetics
Eur J Hum Genet. 2006 volume 14, pages 509–511 doi:10.1038/sj.ejhg.5201600
Pharmacogenetics (draft)
Polymorphic sequence variants in medicine: Technical, social, legal and ethical issues Pharmacogenetics as an example (Draft Background Document) - More
Genetic services
Provision of genetic services in Europe: current practices and issues - More
Population genetic screening
Population genetic screening programmes: technical, social and ethical issues - More
Data storage and biobanking
Data storage and DNA banking for biomedical research: technical, social and ethical issues - More
Insurance
Genetic information and testing in insurance and employment: technical, social and ethical issues - More
Other Publications
Article: Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market - More
Pascal Borry & Martina C. Cornel & Heidi C. Howard
ESHG Responses
PEC-EHSG response to the Human Genetics Commission consulation on A Common Framework of Principles for direct-to-consumer genetic testing services - More
ESHG response to the European Parliament Report on the ethical, legal, economic and social implications of human genetics - <link 123.0.html - internal-link "Opens internal link in current window">More</link>
Letter of the ESHG PEC to members of the European Parliament concerning "A European action in the field of rare diseases" (vote on 23 April 2009) - More
ESHG reponse to the EU consultation on "Rare diseases: Europe's challenge" - More